Protection for pacemaker debuts in-man
Researchers at the Federal Institute of Technology in Zurich and colleagues in Germany have developed a protection for pacemakers. It has now been implanted in a human patient for the first time.
Barry Callebaut launches milk-free chocolate
Barry Callebaut has developed the first chocolate to not contain milk. As a substitute, the chocolate manufacturer has used plant-based raw materials exclusively available to the company. Barry Calleb...
AVA Biochem and Michelin driving development of organic molecule
AVA Biochem has developed a technology that allows sugar to be converted into the molecule 5-HMF. This should replace petroleum-based chemicals. Together with the tire manufacturer Michelin, a product...
Scandit shifts Yodel into higher gear
The UK delivery service company Yodel will now be using software developed by Scandit in order to scan package bar codes. This will allow Yodel employees to complete parcel deliveries using their own ...
MSD to open office in Zurich
Merck Sharpe & Dohme (MSD) are planning to open an office in Zurich next year. Around 250 employees would work here. The pharmaceutical group opted for Zurich on account of the city’s “exceptional...
Zurich moves into center of global sports shoe market
Hollywood star The Rock wears them, while Tennis legend Roger Federer has even invested in the company: The Zurich-based company On is the world’s fastest-growing sports shoe brand, conquering the pre...
Facebook strengthens presence in Switzerland
Facebook has announced plans to double its employee count in Zurich to around 200. The social network also intends to strengthen business with corporate clients. Facebook in Zurich has so far largely ...
Ems-Chemie wins National Apprenticeship Award
Ems-Chemie has won the National Apprenticeship Award. The award recognizes companies that offer exemplary apprenticeships. For its part, Ems-Chemie trains apprentices for both its own company and thir...
Securecell plans to go public
Securecell is developing a membrane that could revolutionize the treatment of diabetes patients. The spin-off from the Federal Institute of Technology in Zurich is planning to go public on the Euronex...
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com